113 related articles for article (PubMed ID: 36626282)
21. Clinical research: national survey of U.S. pharmacy-based investigational drug services--1997.
Rockwell K; Bockheim-McGee C; Jones E; Kwon IW
Am J Health Syst Pharm; 1999 Feb; 56(4):337-44. PubMed ID: 10690217
[TBL] [Abstract][Full Text] [Related]
22. Effects of pharmacist interventions on reducing prescribing errors of investigational drugs in oncology clinical trials.
Moon JY; Lee Y; Han JM; Lee MH; Yee J; Song MK; Kim YJ; Gwak HS
J Oncol Pharm Pract; 2020 Jan; 26(1):29-35. PubMed ID: 30832556
[TBL] [Abstract][Full Text] [Related]
23. Readability of Wikipedia Pages on Autoimmune Disorders: Systematic Quantitative Assessment.
Watad A; Bragazzi NL; Brigo F; Sharif K; Amital H; McGonagle D; Shoenfeld Y; Adawi M
J Med Internet Res; 2017 Jul; 19(7):e260. PubMed ID: 28720555
[TBL] [Abstract][Full Text] [Related]
24. Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety.
Blum AB; Shea S; Czeisler CA; Landrigan CP; Leape L
Nat Sci Sleep; 2011; 3():47-85. PubMed ID: 23616719
[TBL] [Abstract][Full Text] [Related]
25. Fee structure for investigational drug studies.
Anandan JV; Isopi MJ; Warren AJ
Am J Hosp Pharm; 1993 Nov; 50(11):2339-43. PubMed ID: 8266958
[TBL] [Abstract][Full Text] [Related]
26. Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology Trials.
Gasperoni L; Masini C; Toscano G; Cafaro A; Zani C; Andrianò C; Silimbani P; Donati C; Bortolin G; Cecco S
Curr Oncol; 2024 May; 31(5):2867-2873. PubMed ID: 38785499
[TBL] [Abstract][Full Text] [Related]
27. Readability levels of individualized family service plans.
Pizur-Barnekow K; Patrick T; Rhyner PM; Folk L; Anderson K
Phys Occup Ther Pediatr; 2010 Aug; 30(3):248-58. PubMed ID: 20608861
[TBL] [Abstract][Full Text] [Related]
28. National survey of pharmacy-coordinated investigational drug services.
Young LM; Haakenson CM; Weber JH; Tosch TJ
Am J Hosp Pharm; 1984 Sep; 41(9):1792-6. PubMed ID: 6496514
[TBL] [Abstract][Full Text] [Related]
29. HOSPITAL PHARMACY'S RESPONSIBILITIES TO SPONSORS OF INVESTIGATIONAL DRUGS.
SKOLAUT MW
Hosp Top; 1965 Aug; 43():91-5. PubMed ID: 14345620
[No Abstract] [Full Text] [Related]
30. Evaluation of nurses' workload in intensive care unit of a tertiary care university hospital in relation to the patients' severity of illness: A prospective study.
Kraljic S; Zuvic M; Desa K; Blagaic A; Sotosek V; Antoncic D; Likic R
Int J Nurs Stud; 2017 Nov; 76():100-105. PubMed ID: 28950187
[TBL] [Abstract][Full Text] [Related]
31. Work hours of residents in seven anesthesiology training programs.
Berry AJ; Hall JR
Anesth Analg; 1993 Jan; 76(1):96-101. PubMed ID: 8418748
[TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacy workload in medical and surgical patients: effect of patient partition, disease complexity and major disease category.
Stuchbery P; Kong DC; DeSantis GN; Lo SK
Int J Pharm Pract; 2010 Jun; 18(3):159-66. PubMed ID: 20509349
[TBL] [Abstract][Full Text] [Related]
33. The quality, understandability, readability, and popularity of online educational materials for heart murmur.
Arslan D; Sami Tutar M; Kozanhan B; Bagci Z
Cardiol Young; 2020 Mar; 30(3):328-336. PubMed ID: 31875800
[TBL] [Abstract][Full Text] [Related]
34. Comprehensibility of translated informed consent documents used in clinical research in psychiatry.
Jhanwar VG; Bishnoi RJ
Indian J Psychol Med; 2010 Jan; 32(1):7-12. PubMed ID: 21799552
[TBL] [Abstract][Full Text] [Related]
35. Assessment of perceived workload in academic health center community pharmacies before and after implementation of a central call center.
Legenza L; Nickman NA; Drews FA; Rim M; Tigh J; Kelly MP; Tyler LS
Am J Health Syst Pharm; 2019 Oct; 76(21):1794-1805. PubMed ID: 31612926
[TBL] [Abstract][Full Text] [Related]
36. House staff team workload and organization effects on patient outcomes in an academic general internal medicine inpatient service.
Ong M; Bostrom A; Vidyarthi A; McCulloch C; Auerbach A
Arch Intern Med; 2007 Jan; 167(1):47-52. PubMed ID: 17210877
[TBL] [Abstract][Full Text] [Related]
37. Drug cost savings in phase III hematological oncology clinical trials in a university hospital.
Herledan C; Ranchon F; Schwiertz V; Baudouin A; Karlin L; Ghesquières H; Salles G; Rioufol C
Hematol Oncol; 2020 Oct; 38(4):576-583. PubMed ID: 32469095
[TBL] [Abstract][Full Text] [Related]
38. Economic benefits of investigational drug services at an academic institution.
LaFleur J; Tyler LS; Sharma RR
Am J Health Syst Pharm; 2004 Jan; 61(1):27-32. PubMed ID: 14725117
[TBL] [Abstract][Full Text] [Related]
39. Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?
Grossman SA; Piantadosi S; Covahey C
J Clin Oncol; 1994 Oct; 12(10):2211-5. PubMed ID: 7931491
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
